Description

Romagnuolo et al identified clinical and laboratory findings associated with significant liver pathology in patients with chronic hepatitis C viral (HCV) infections. The authors are from McGill University and the University of Alberta in Edmonton.


 

Patient selection: adults (age >= 18 years) with chronic viral hepatitis C

 

Parameters associated with significant inflammation (active hepatitis)

(1) spider nevi

(2) ferritin > 200 µg/L

(3) albumin <= 3.5 g/dL

(4) hepatomegaly

(5) splenomegaly

(6) WBC count <= 4,000 per µL

(7) ALT > 120 IU/L (3 times the upper limit of normal reference range)

(8) bilirubin > 20 µmol/L

 

Predictive model for significant inflammation:

(1) ferritin >= 200 µg/L

(2) presence of spider nevi and/or albumin <= 3.5 g/dL

 

The probability of significant inflammation is high if 2 of the criteria are present. The risk is very low if no criteria are present.

 

Parameters associated with significant fibrosis:

(1) age >= 40 years of age

(2) spider nevi

(3) history of decompensation

(4) hepatomegaly

(5) splenomegaly

(6) WBC count <= 4,000 per µL

(7) platelet count <= 150,000 per µL

(8) INR > 1.2

(9) albumin <= 3.5 g/dL

 

Predictive model for significant fibrosis:

(1) spider nevi

(2) platelet count <= 150,000 per µL

(3) splenomegaly and/or albumin <= 3.5 g/dL

 

The probability of significant fibrosis is high if 2 or 3 of the criteria are present. The risk is low if no criteria are present.

 

Parameters associated with cirrhosis:

(1) ALT > 120 IU/L

(2) spider nevi

(3) history of decompensation

(4) hepatomegaly

(5) splenomegaly

(6) total bilirubin > 20 µmol/L

(7) platelet count <= 150,000 per µL

(8) INR > 1.2

(9) albumin <= 3.5 g/dL

 


To read more or access our algorithms and calculators, please log in or register.